16-30353744-C-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_006110.3(CD2BP2):c.432G>T(p.Glu144Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000609 in 1,609,346 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006110.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD2BP2 | NM_006110.3 | c.432G>T | p.Glu144Asp | missense_variant | 5/7 | ENST00000305596.8 | NP_006101.1 | |
CD2BP2 | NM_001243646.2 | c.432G>T | p.Glu144Asp | missense_variant | 4/6 | NP_001230575.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD2BP2 | ENST00000305596.8 | c.432G>T | p.Glu144Asp | missense_variant | 5/7 | 1 | NM_006110.3 | ENSP00000304903 | P1 | |
CD2BP2 | ENST00000569466.1 | c.432G>T | p.Glu144Asp | missense_variant | 4/6 | 1 | ENSP00000456935 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152220Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000406 AC: 1AN: 246218Hom.: 0 AF XY: 0.00000746 AC XY: 1AN XY: 134032
GnomAD4 exome AF: 0.0000666 AC: 97AN: 1457126Hom.: 0 Cov.: 33 AF XY: 0.0000607 AC XY: 44AN XY: 724384
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152220Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74376
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 18, 2023 | The c.432G>T (p.E144D) alteration is located in exon 5 (coding exon 4) of the CD2BP2 gene. This alteration results from a G to T substitution at nucleotide position 432, causing the glutamic acid (E) at amino acid position 144 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at